mtDNA, or mitochondrial DNA, is the small mitochondrial genome that serves as an editing target and a regulator of mitochondrial-nuclear communication, with its copy number and heteroplasmy shaping cellular responses. It is involved in innate immune activation and inflammatory signaling, including cgas sting and nlrp3 inflammasome pathways, and its release from structurally intact mitochondria can occur under subtoxic oxidative stress. Recent work also shows that CRISPR/Cas9-based mitochondrial genome editing can reduce mtDNA copy number and contribute to tumor cell apoptosis, highlighting a potential therapeutic mechanism. In addition, mtDNA depletion has been linked to perturbations caused by loss of opa1, polg, or tfam, underscoring its central role in mitochondrial maintenance.
Cancer
- A spatiotemporally regulated CRISPR/Cas9 nanoplatform edited mitochondrial genomes in tumor cell mitochondria and reduced mtDNA copy number, contributing to tumor cell apoptosis. (PMID:41584446)
- The Chemical Science 2026 study (PMID:41584446) supports mtDNA as a therapeutic editing target in cancer-relevant mitochondria.
- mtDNA-level control was also used in a mitochondria-targeted nanosystem designed to modulate inflammatory states that can support disease treatment. (PMID:41512500)
Inflammation and Innate Immunity
- mtDNA implicated activation of the cgas sting signaling pathway and downstream inflammatory cascades. (PMID:41512500)
- Released mtDNA activated the nlrp3 inflammasome, linking mitochondrial stress to innate immune signaling. (PMID:41512500)
- VDAC1-dependent mtDNA release was attenuated by inhibiting VDAC1 oligomerization, reducing fibroblast innate immune activation. (PMID:41722540)
- A 2026 International Immunopharmacology study (PMID:41722540) connected mtDNA release to vitiligo pathogenesis.
- A mitochondria-targeted co-assembled nanosystem with multimodal mtDNA level control was developed to alleviate inflammation and promote chronic wound healing. (PMID:41512500)
Mitochondrial Genetics and Genome Homeostasis
- MitoPerturb-Seq interrogated nuclear genes and pathways that sense and control mtDNA copy number and heteroplasmy. (PMID:41922875)
- The Nature Structural & Molecular Biology 2026 study (PMID:41922875) showed gene-specific single-cell responses to mtDNA depletion and heteroplasmy.
- Knockout of opa1, polg, or tfam caused mtDNA depletion, highlighting core regulators of mitochondrial genome maintenance. (PMID:41922875)
- mtDNA copy number and heteroplasmy were studied in relation to disease-relevant mitochondrial-nuclear interactions. (PMID:41922875)